| Ba Vision | |
|
521 S Aspen Ave, Broken Arrow, OK 74012-2296 | |
| (918) 258-9999 | |
| (918) 258-2850 |
| Full Name | Ba Vision |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 521 S Aspen Ave, Broken Arrow, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194979765 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Stacey D Murrell |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1619984481 PECOS PAC ID: 5395801682 Enrollment ID: I20090312000217 |
News Archive
ReachMD LLC and ReachMD XM Radio 160, a leading multi-media provider of advanced healthcare education and information, teamed with Dr. Nancy Snyderman, Chief Medical Editor of NBC News, and on staff in the Department of Otolaryngology-Head and Neck Surgery at the University of Pennsylvania, to present the winner of "ReachMD's Next Top Doc" quiz show with the ReachMD $5000.00 Educational Scholarship.
In many species, including humans and mice, the fluctuating levels of the hormones progesterone and estrogen determine whether the female is fertile or not. And in the case of mice, whether she's sexually receptive or not.
Tibotec Pharmaceuticals announced today the company will present the results of a Week-24 planned interim analysis of the phase 2 response-guided PILLAR study in treatment-naive patients with chronic genotype 1 hepatitis C virus (HCV) at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, MA., USA. The data will be presented as part of a late-breaker oral presentation on Monday, November 1.
The FDA announced Thursday that it is beginning a pilot project with Medicare officials in an effort to get new medical products covered sooner for the nation's 45 million senior citizens. Under the proposal, the FDA would review and make approval decisions alongside the Centers for Medicare and Medicaid Services, which decides whether and how to pay for new medical products for its elderly and disabled patients once they are approved for the U.S. market," Reuters reported.
Kalidex Pharmaceuticals, a privately-held anti-infective company, today announced the presentation of data on its lead development candidate KPI-10, a broad spectrum, next-generation fluoroquinolone, at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, September 9 through 12.
› Verified 1 days ago
| Provider Name | Colby Beats |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1043227812 PECOS PAC ID: 6103983929 Enrollment ID: I20090324000082 |
News Archive
ReachMD LLC and ReachMD XM Radio 160, a leading multi-media provider of advanced healthcare education and information, teamed with Dr. Nancy Snyderman, Chief Medical Editor of NBC News, and on staff in the Department of Otolaryngology-Head and Neck Surgery at the University of Pennsylvania, to present the winner of "ReachMD's Next Top Doc" quiz show with the ReachMD $5000.00 Educational Scholarship.
In many species, including humans and mice, the fluctuating levels of the hormones progesterone and estrogen determine whether the female is fertile or not. And in the case of mice, whether she's sexually receptive or not.
Tibotec Pharmaceuticals announced today the company will present the results of a Week-24 planned interim analysis of the phase 2 response-guided PILLAR study in treatment-naive patients with chronic genotype 1 hepatitis C virus (HCV) at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, MA., USA. The data will be presented as part of a late-breaker oral presentation on Monday, November 1.
The FDA announced Thursday that it is beginning a pilot project with Medicare officials in an effort to get new medical products covered sooner for the nation's 45 million senior citizens. Under the proposal, the FDA would review and make approval decisions alongside the Centers for Medicare and Medicaid Services, which decides whether and how to pay for new medical products for its elderly and disabled patients once they are approved for the U.S. market," Reuters reported.
Kalidex Pharmaceuticals, a privately-held anti-infective company, today announced the presentation of data on its lead development candidate KPI-10, a broad spectrum, next-generation fluoroquinolone, at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, September 9 through 12.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ba Vision 521 S Aspen Ave, Broken Arrow, OK 74012-2296 Ph: (918) 258-9999 | Ba Vision 521 S Aspen Ave, Broken Arrow, OK 74012-2296 Ph: (918) 258-9999 |
News Archive
ReachMD LLC and ReachMD XM Radio 160, a leading multi-media provider of advanced healthcare education and information, teamed with Dr. Nancy Snyderman, Chief Medical Editor of NBC News, and on staff in the Department of Otolaryngology-Head and Neck Surgery at the University of Pennsylvania, to present the winner of "ReachMD's Next Top Doc" quiz show with the ReachMD $5000.00 Educational Scholarship.
In many species, including humans and mice, the fluctuating levels of the hormones progesterone and estrogen determine whether the female is fertile or not. And in the case of mice, whether she's sexually receptive or not.
Tibotec Pharmaceuticals announced today the company will present the results of a Week-24 planned interim analysis of the phase 2 response-guided PILLAR study in treatment-naive patients with chronic genotype 1 hepatitis C virus (HCV) at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, MA., USA. The data will be presented as part of a late-breaker oral presentation on Monday, November 1.
The FDA announced Thursday that it is beginning a pilot project with Medicare officials in an effort to get new medical products covered sooner for the nation's 45 million senior citizens. Under the proposal, the FDA would review and make approval decisions alongside the Centers for Medicare and Medicaid Services, which decides whether and how to pay for new medical products for its elderly and disabled patients once they are approved for the U.S. market," Reuters reported.
Kalidex Pharmaceuticals, a privately-held anti-infective company, today announced the presentation of data on its lead development candidate KPI-10, a broad spectrum, next-generation fluoroquinolone, at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, September 9 through 12.
› Verified 1 days ago
Dr. Kelly Glass, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2500 W New Orleans St, Broken Arrow, OK 74011 Phone: 918-893-3769 Fax: 918-286-8281 | |
Colby Beats, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 521s Aspen Ave, Broken Arrow, OK 74012 Phone: 918-258-9999 Fax: 918-258-2850 | |
Dr. James Thirion, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3505 W Kenosha St, Broken Arrow, OK 74012 Phone: 918-286-2020 | |
Dr. Alfonso Hernandez Jr., OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3505 W Kenosha St, Broken Arrow, OK 74012 Phone: 918-286-2020 | |
Thomas H Berenson O D P C Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3300 S Aspen Ave, Ste D, Broken Arrow, OK 74012 Phone: 918-451-2020 Fax: 918-449-9086 | |
Dr. Tracy L Shoemaker, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4008 S Elm Pl, Ste A, Broken Arrow, OK 74011 Phone: 918-455-2020 Fax: 918-455-4030 |